ABSTRACT-Sepsis is a systemic inflammatory response as a result of uncontrolled infections. Neutrophils are the first cells to reach the primary sites of infection, and chemokines play a key role in recruiting neutrophils. However, in sepsis chemokines could also contribute to neutrophil infiltration to vital organs leading to multiple organ failure. ACKR2 is an atypical chemokine receptor, which can remove and degrade inflammatory CC chemokines. The role of ACK2 in sepsis is unknown. Using a model of cecal ligation and puncture (CLP), we demonstrate here that ACKR2 deficient ( À/À ) mice exhibited a significant reduction in the survival rate compared with similarly treated wild-type (WT) mice. However, neutrophil migration to the peritoneal cavity and bacterial load were similar between WT and ACKR2 À/À mice during CLP. In contrast, ACKR2 À/À mice showed increased neutrophil infiltration and elevated CC chemokine levels in the lung, kidney, and heart compared with the WT mice. In addition, ACKR2
INTRODUCTION
Sepsis is a life-threatening organ dysfunction caused by dysregulated host response to infection (1) . The recruitment of neutrophils to an infected area counters the infection and avoids pathogen spreading to the circulation (2) (3) (4) . However, the infiltration of neutrophils into vital organs contributes to organ dysfunction during sepsis and, consequently, to death. Both processes are mainly mediated by signaling of the G protein-coupled receptor, including the chemokine receptors (5, 6) .
ACKR2 is an atypical chemokine receptor that does not signal via G protein because of a modification in the G proteinbinding domain (DRYLAIV motif is altered to DKYLEIV) (7) . However, ACKR2 binds with high affinity to inflammatory chemokines from the CC subfamily leading to receptor internalization and CC chemokines degradation (7) (8) (9) , and contributes to the resolution of several inflammatory conditions (7, (10) (11) (12) (13) . However, the role of ACKR2 receptor in the pathophysiology of sepsis is hitherto unknown.
In the present study, we hypothesized that ACKR2 could contribute to the degradation of chemokines in the foci of infection or in the vital organs, leading, in the first case, to aggravation of sepsis and, in the second case, to protection. To test these possibilities, we used ACKR2 knockout ( À/À ) mice in a model of cecal ligation and puncture (CLP) to induce different severities of sepsis.
MATERIALS AND METHODS

Mice
Experiments were performed on both male and female mice between 6 and 8 weeks old. C57BL/6 (wild-type, WT) mice were obtained from the animal facility of the University of São Paulo, São Paulo, Brazil. ACKR2
À/À mice on the C57BL/6 background were generated and donated by Professor Sergio Lira (Icahn School of Medicine at Mount Sinai, NY) (10) (11) . The study was approved by the Ethics Committee for the Use of Animals (CEUA) of Ribeirão Preto Medical School, University of Sao Paulo (protocol number 105/2014).
The care and treatment of the animals were based on the Guide for the Care and Use of Laboratory Animals (14) .
Sepsis model
CLP was used to induce nonsevere (NS-CLP) and severe sepsis (S-CLP). Briefly, the animals were anesthetized with ketamine and xylazine diluted in PBS (100 mg/kg ketamine and 10 mg/kg xylazine; União Quimica, BR). The cecum of the animals was exposed, ligated, and punctured, according to the severity of sepsis (one puncture with 21G needle and one puncture with 18G needle to induce nonsevere and severe sepsis, respectively). Next, the cecum was repositioned in the abdomen, and the peritoneal wall was closed. The animals received 1 mL of saline subcutaneously after this procedure to avoid dehydration. Sham-operated mice were under laparotomy without CLP. The group of animals treated with antibiotic received an intraperitoneal injection of ertapenem sodium (20 mg/kg; Merck Research Laboratory, Whitehouse Station, NJ) beginning 6 h after CLP and then every 12 h up to day 3. The survival of mice was recorded every 12 h for 10 days. Mice showing signs of ataxia, tremor, and/or agonal breathing were euthanized by overdose of ketamine/ xylazine followed by cervical dislocation. At the end of 10 days, surviving mice were euthanized. Some mice were also euthanized at different time points after CLP for biochemical and cell migration analysis. It should be noted that the phenotype of ACKR2 À/À mice could be variable in this sepsis model. However, when the mice were treated with antibiotics, the ACKR2 À/À mice remained consistently more susceptible to CLP. Thus, the variability observed was most likely due a change of microbiota in the mice over the years in a conventional SPF environment.
In vivo determination of neutrophil migration
Neutrophil migration was determined 24 and 36 h after CLP as previously described (15) . Briefly, the animals were euthanized and the peritoneal cavity was washed with 1.5 mL of PBS containing 1 mM EDTA. Total cell counts from the lavage were performed with a cell counter (Coulter AC T series analyzer; Coulter Corp., Miami, Fla), and differential cell counts were carried out on cytocentrifuge slides (Cytospin 3; Shandon Southern Products, Astmoore, UK) and stained by the May-Grünwald-Giemsa (Rosenfeld) method.
Bacterial counts
Bacterial counts were determined 24 and 36 h after CLP as previously described (16) . Briefly, mice were euthanized and peritoneal lavage fluid and blood were harvested, diluted serially with sterile PBS, plated on Muller-Hinton agar dishes (Difco Laboratories, Detroit, Mich), and incubated at 378C for 18 h and colony-forming units (CFUs) were visually counted.
Chemokine assay
The concentrations of chemokines in the lungs, kidneys, and heart were measured 24 h after CLP and in the peritoneal lavage 24 and 36 h after CLP. The lung, kidney, and heart tissues were homogenized, and the concentration of chemokine in the supernatant was determined by ELISA kits (R&D Systems) as previously described (17) .
Myeloperoxidase activity assay
Tissue myeloperoxidase (MPO) activity was used as a biochemical index of neutrophil infiltration into the lung, kidney, and heart as previously described (18) .
Assessment of lung resistance
Mice were anesthetized with a subcutaneous injection of ketamine and xylazine (130 mg/kg ketamine and 8.5 mg/kg xylazine) to maintain spontaneous breathing under anesthesia. Mice were tracheostomized, placed in a body plethysmograph, and connected to a computer-controlled ventilator (Forced Pulmonary Maneuver System, Buxco Research Systems, Wilmington, NC). This laboratory set-up, specifically designed for mice, has only a canula volume (death space) of 0.8 mL and provides semiautomatically three different maneuvers: Boyle's Law FRC, quasistatic pressure-volume, and fast-flow volume maneuver. First, an average breathing frequency of 160 breaths/min was imposed to the anesthetized animal by pressure-controlled ventilation until a regular breathing pattern and complete expiration at each breathing cycle was obtained. Under mechanical respiration, the lung resistance (Rl) was determined as previously described (19) .
Blood urea nitrogen assays
Animals were euthanized 24 h after CLP, and blood was collected to measure renal dysfunction assessed by blood urea nitrogen (BUN) levels. The assays were performed according to the specification of a commercial kit (Labtest, Brazil).
Real-time q-PCR
Lung, kidney, and heart were collected in trizol (Sigma) 12 or 24 h after CLP and macerated for extraction of total RNA. After extraction, an aliquot of 1 mL was used to determine the RNA concentration by reading in NanoDrop (Thermo Fisher Scientific), and 1 mg of the extracted RNA was used for the cDNA conversion using the High-Capacity cDNA Reverse transcription kit (Life Technologies) in a thermal cycler. The cDNA was used for the quantification of the Ccbp2 (ACKR2) gene expression (TaqMan Assay: Mm00445551_m1) by real-time PCR using TaqMan Universal Master Mix II, at the UNG, according to the manufacturer's instruction (Life Technologies). Gapdh gene (TaqMan Assay: Gapdh-Mm99999915_g1) was used as a control for normalization of expression levels. The real-time quantitative reaction was performed in the Viia 7 Real-Time PCR System (Applied Biosystems). The results were analyzed using the 2ÀDDCT method and are expressed in relation to the reference group (sham).
Patient samples
Lung samples from patients who died of sepsis (n ¼ 11) and controls (n ¼ 11, individuals who died of other causes), that were stored in paraffin blocks (at the Clinical Hospital, Department of Pathology, Ribeirao Preto Medical School), were used in this study. In addition, sample from four patients with chronic obstructive pulmonary disease (COPD) were used as control for the antibody. The median of the age of the individuals included in the study was 36 for the septic patients and 38 for the control patients. 27% and 54% of the controls and septic patients, respectively, were female. The procedures performed with these samples were approved by the Committee of Ethics in Research with Human Subjects (CEP), Certificate of Presentation for Ethical Assessment (CAAE) 54775416.5.0000.5440 and official approval number 1579/2016.
FIG. 2. CC chemokine levels are increased in secondary organs of ACKR2
À/À mice after CLP. WT and ACKR2 À/À mice underwent sham or nonsevere CLP and the level of CCL3 in the lung (A), CCL5 in the kidney (B), and CCL2 (C) and CCL3 (D) in the heart were measured. The results are whiskers (min to max), and were analyzed by ANOVA followed by Bonferroni, n ¼ 4-6 animals/group,
Immunohistochemistry for ACKR2
After deparaffinization and hydration, the slides (5 mm) were incubated for 30 min in 0.5% H 2 O 2 diluted in methanol. The slides were then washed in TBST/Tween (0.05%) for further incubation in 0.01 M citrate buffer (pH ¼ 6.0) for 5 min at 1008C. After washing in TBST/Tween, the sections were incubated with Fc block for 30 min and in 2.5% horse serum for a further 30 min. The slides were then labeled with anti-ACKR2 polyclonal rabbit antibody (Sigma) overnight, at 48C. The slides were then washed and incubated with an antirabbit secondary antibody (Vector Labs, Peterborough, UK) for 1 h at room temperature. After washing, peroxidase-conjugated streptavidin (Vector Labs, Peterborough, UK; 30 min, room temperature) was added and the slides were incubated with DAB for 2 min. After hydration, the slides were stained with hematoxylin and assembled with mounting medium. ACKR2 expression analyzes were performed at 400Â magnification, and 20 fields were evaluated per slide. The number of positive cells for ACKR2þ cells was counted visually, and the results are expressed as mean number of ACKR2 positive cells per field.
Statistical analyzes
The statistical analyzes were performed using GraphPad Prism. Survival rates were analyzed by Mantel-Cox log-rank test. Bacterial counts are expressed as medians, and all other mouse data are expressed as box-and-whiskers (Min to Max). The human data are expressed as dot-plot and mean. The human data were analyzed by t test and all the others by ANOVA followed by Bonferroni.
RESULTS
ACKR2-deficient mice are more susceptible to CLP-induced sepsis
To investigate the potential role of ACKR2 in the pathogenesis of sepsis, we first compared the survival rate of WT and ACKR2 À/À mice under different severities of CLP-induced sepsis. In the severe model of CLP (S-CLP), all mice died within 3 days after CLP and there was no difference in the survival rate between the WT and ACKR2 À/À mice. However, in the nonsevere model of sepsis (NS-CLP), ACKR2
À/À mice were significantly more susceptible than the WT mice (survival rate: 88% in WT animals vs. 33% in the ACKR2 À/À group) (Fig. 1A) . These results indicate that ACKR2 plays a significant role in protecting mice against sepsis.
We have previously shown that neutrophil migration to the primary site of infection (peritoneal cavity) during CLP is crucial for preventing the spreading of microorganisms to the circulation and thus avoiding the aggravation of sepsis (15, 20) . We therefore determined neutrophil migration and the
FIG. 3. ACKR2
À/À mice have increased neutrophils and lesion in peripheral organs after CLP. WTand ACKR2 À/À mice underwent sham or NS-CLP. The neutrophil infiltration in the lung (A), kidney (B), and heart (C) were measured by myeloperoxidase (MPO) activity. (D) Blood urea nitrogen (BUN) and (E) lung resistance were measured 24 h after CLP. The results are whiskers (min to max), and were analyzed by ANOVA followed by Bonferroni, n ¼ 5-7, * P < 0.05. Data are representative of two experiments (A-C, E).
bacterial load in the peritoneal cavity and in the blood. Surprisingly, there was no significant difference in the number of neutrophils in the peritoneal cavity between the WT and ACKR2 À/À mice under the NS-CLP (Fig. 1B) . Consistent with this observation, the level of chemokines (CXCL2, CCL2, CCL3, and CCL5) in the peritoneal cavity was also similar in WT and ACKR2 À/À mice after NS-CLP (Fig. 1, C-F) . In addition, the bacterial loads in the peritoneal cavity (Fig. 1G ) and in the circulation (Fig. 1H) were also similar between WT and ACKR2 À/À animals. These results indicate that the increased severity of the ACKR2 À/À mice was likely to be due to factors other than the reduction of neutrophil migration and bacterial load in the peritoneal cavity.
ACKR2 controls chemokines accumulation and neutrophil infiltration in secondary organs during sepsis
We and others have shown that CC chemokines are increased in secondary organs and induce neutrophil accumulation after sepsis induction (21). We therefore investigated the possible role of ACKR2 in the control of the systemic inflammatory response. Lung, kidney, and heart were collected 24 h after NS-CLP, and the concentrations of chemokine in the tissue homogenates were determined by ELISA. There was a significant increase in the level of CCL3 in the lung (Fig. 2A) , CCL5 in the kidney (Fig. 2B), and CCL2 (Fig. 2C) and CCL3 (Fig. 2D ) in the heart of ACKR2 À/À mice compared with those of the WT mice.
Consistent with this observation, the number of neutrophils was also significantly increased in the lung, kidney, and heart of the ACKR2 À/À mice compared with those of the WT mice (Fig. 3, A-C) . The increase in the number of neutrophils would be expected to lead to exacerbated organ damage. This is shown by a significant increase in the BUN (a measurement of kidney damage) levels (Fig. 3D) and by a tendency to increase in the lung resistance (Fig. 3E) 
in the ACKR2
À/À mice compared with those of the WT mice under NS-CLP.
Ackr2 mRNA is induced in vital organs after sepsis
We then investigated whether the expression of ACKR2 is affected by sepsis induction. WT mice were given either nonsevere sepsis (NS-CLP) or severe sepsis (S-CLP) and their organs harvested 12 or 24 h after CLP. Ackr2 mRNA levels in the lung 12 h (Fig. 4A ) and 24 h (Fig. 4B) after CLP, kidney 24 h after CLP (Fig. 4C) , and heart 24 h after CLP (Fig. 4D) were significantly increased in the mice with NS-CLP compared with those of the control sham-operated mice. In contrast, although Ackr2 expression was also increased in the lungs of mice under S-CLP 12 h after surgery, its expression returned to the level of the control mice by 24 h. In addition, the levels of ACKR2 mRNA in the kidney and heart of the mice with S-CLP were also not significantly different from those of the control mice 24 h after sepsis induction. These results indicate that the sustained higher level of Ackr2 mRNA expression is correlated with increased level of survival of septic mice, and hence support the notion that ACKR2 are protective against sepsis through its elevated levels in the vital organs.
The effect of antibiotics on the sepsis in ACKR2 S/S mice To confirm that the protective role of ACKR2 during sepsis is due to the participation of this receptor in the systemic inflammatory response, rather than in the control of the local response against the infection, we next used a lethal sepsis model (S-CLP), which induces an exacerbated inflammatory response, and then treat the animals with antibiotics to control the infection. Treatment of mice under S-CLP with antibiotics significantly reduced bacteremia and improved the survival of WT animals, as previously shown (22) . Although none of the WT mice survived after day 2 of S-CLP (without antibiotic), 40% of WT mice treated with the antibiotic survived S-CLP. In contrast, all the ACKR2 À/À mice died from S-CLP by day 2.5 whether treated with antibiotics (Fig. 5A ). In addition, the ACKR2 À/À mice showed higher levels of MPO in the lung, kidney, and heart than those of the WT mice after S-CLP and antibiotic treatment (Fig. 5, B-D) . These results therefore confirm that the higher mortality rate in the ACKR2 À/À mice was not due to local infection. Instead, the high susceptibility of the ACKR2 À/À mice was likely to be due to inflammatory response in the vital organs.
ACKR2 expression in patients with sepsis
Finally, we investigated whether the expression of ACKR2 is also altered in the lungs of patients with sepsis. We stained for ACKR2 positive cells in the lung tissues of 11 patients with sepsis and 11 control samples from nonseptic patients. The analysis of the expression of ACKR2 þ cells in the lung of septic patients showed clear and markedly elevated number of ACKR2 þ cells in comparison with control patients (Fig. 6 , A-C). As positive control for the antibody used, we also stained ACKR2 in patients with COPD (Fig. 6D) . Morphological analysis indicates that the ACKR2 þ cells are macrophage-like cells. These results are consistent with the elevated levels of Ackr2 mRNA expression in the lungs of mice during the early stage of severe sepsis (Fig. 4A) .
DISCUSSION
Data reported here demonstrate a hitherto unrecognized protective role of the atypical chemokine receptor, ACKR2, in sepsis. ACKR2 is induced during sepsis, and it attenuates the damage to the vital organs caused by sepsis, most likely by reducing the level of local CC chemokines, which are potent mediators in recruiting activated neutrophils to these organs and hence causing damage to the organs. Interestingly, ACKR2 had little or no effect on the levels of chemokines and the number of neutrophils in the primary foci of infection (peritoneal cavity). Consequently, ACKR2 also had no effect on the bacterial load in the peritoneal cavity or in the peripheral blood. The dichotomy effect of ACKR2 seen here is consistent with the emerging concept separating the control of bacteremia from limiting inflammatory organ damage in the management of sepsis (23) . Resistance to pathogens does not always confer protection from multiple organ damage (24) . This is clearly borne out in our study showing that the control of bacterial load by antibiotics did not rescue the ACKR2 À/À mice from multiple organ damage caused by the high level of chemokines and neutrophil infiltration in the lung, kidney, and heart. This observation is also consistent with a recent observation that treatment of mice under CLP-induced sepsis with anthracycline, a compound used for the treatment of cancer, improved the survival of mice by increasing autophagy and reducing lung injury without affecting the bacterial load, suggesting that anthracycline treatment protected the organ damage during sepsis (25) . In addition, animals deficient in the enzyme hemeoxygenase are more susceptible to sepsis, due to increased organ damage with no change in the pathogen load (26) .
The levels of systemic cytokines and chemokines vary with the severity of the disease during sepsis. Clinically, the levels of CCL2 and CCL3 are elevated systemically during severe sepsis or septic shock compared with nonsevere sepsis (27) . One possible explanation is that during severe sepsis the further spread of the pathogens into the bloodstream leads to increased activation of the host cells, culminating in the increased production of the inflammatory mediators. Here we are showing an alternative mechanism based on the fact that ACKR2 expression is increased in the lungs, kidney, and heart of WT mice after the induction of nonsevere sepsis, but not in severe sepsis. Thus, the higher tissue levels of inflammatory CC chemokines during severe sepsis could be also due to the failure to remove and degradate these chemokines by the reduced levels of ACKR2 in these organs. In psoriasis, it was demonstrated that ACKR2 expression is increased in uninvolved skin regions of patients. However, the expression of ACKR2 is reduced or absent in damaged regions. Associated with this, the skin inflammation is increased in regions with injuries, or in areas with low ACKR2 expression (28) . In addition, transgenic expression of ACKR2 in keratinocytes prevented the growth of skin tumors in mice by the reduction of skin inflammation (12) . However, the mechanism by which ACKR2 is modulated during sepsis and in these other pathologies is currently unknown and warrants further investigation.
Our clinical data showing that the lungs of septic patients had increased frequency of ACKR2 þ cells may, at first, seem counterintuitive. However, our data from murine sepsis show that both severe and nonsevere septic mice exhibited elevated Ackr2 mRNA at 12 h time point, suggesting that the observed increased frequency of ACKR2 þ cells in the lungs of the sepsis patients is not inconsistent with a role of ACKR2 in clinical sepsis. Thus, the observed elevated levels of ACKR2 in the patients who succumbed to sepsis may represent a failed attempt by these patients to control the disease. However, this hypothesis is ethically untestable. In corroboration, alveolar macrophages from patients with chronic COPD also express ACKR2 and may, in same way, control the acute lung injury during this disease (29) .
Sepsis is a complex condition likely involved the interplay of multiple regulatory factors and mediators. Our finding that ACKR2 plays a substantive protective role reducing remote organ injury in sepsis suggests that ACKR2 may be a potential therapeutic agent in this important and clinically unmet condition.
